BridGene Biosciences names David Sperandio, Ph.D., as Head of Chemistry
SAN JOSE, Calif., Aug. 1, 2022 /PRNewswire/ — BridGene Biosciences, Inc., a biotechnology company using a proprietary chemoproteomics technology to discover and develop small molecules for high value, traditionally undruggable targets, today announced that David Sperandio, Ph.D., a…
Comments Off on BridGene Biosciences names David Sperandio, Ph.D., as Head of Chemistry